Tag: Juno Therapeutics

Gida / Kafa Shekara

, , , ,

Lisocabtagene maraleucel an amince da shi ta FDA don maganin layi na biyu na babban lymphoma B-cell

Yuli 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) an amince da shi ta Cibiyar Abinci da Magunguna don manya marasa lafiya tare da babban lymphoma B-cell (LBCL) waɗanda ke da cututtukan da ba su da ƙarfi zuwa chemoi na farko.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton